LARS1 and neoplasm: As an identified compound facilitating the interaction of LMNA with c‐Myc, lobeline inhibits EPRS and LARS expression, MAS, aerobic glycolysis and tumour progression, suggesting the essential interplay of LMNA and c‐Myc in tRNA processing essential for MAS during tumour progression.